263 related articles for article (PubMed ID: 26006087)
21. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
Wang T; Wang N
Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
[TBL] [Abstract][Full Text] [Related]
22. Current Progress in Particle-Based Systems for Transdermal Vaccine Delivery.
Pielenhofer J; Sohl J; Windbergs M; Langguth P; Radsak MP
Front Immunol; 2020; 11():266. PubMed ID: 32174915
[TBL] [Abstract][Full Text] [Related]
23. Transfollicular delivery takes root: the future for vaccine design?
Hansen S; Lehr CM
Expert Rev Vaccines; 2014 Jan; 13(1):5-7. PubMed ID: 24428204
[TBL] [Abstract][Full Text] [Related]
24. Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.
Matsuo K; Hirobe S; Okada N; Nakagawa S
Vaccine; 2013 May; 31(19):2403-15. PubMed ID: 23523401
[TBL] [Abstract][Full Text] [Related]
25. Microneedles for vaccine delivery: challenges and future perspectives.
Shin CI; Jeong SD; Rejinold NS; Kim YC
Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
[TBL] [Abstract][Full Text] [Related]
26. Transcutaneous vaccines--current and emerging strategies.
Hirobe S; Okada N; Nakagawa S
Expert Opin Drug Deliv; 2013 Apr; 10(4):485-98. PubMed ID: 23316778
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
28. Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.
Herzog C
Expert Rev Vaccines; 2014 Mar; 13(3):399-415. PubMed ID: 24512188
[TBL] [Abstract][Full Text] [Related]
29. Understanding the murine cutaneous dendritic cell network to improve intradermal vaccination strategies.
Ginhoux F; Ng LG; Merad M
Curr Top Microbiol Immunol; 2012; 351():1-24. PubMed ID: 21058006
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous immunization: an evolving paradigm in influenza vaccines.
Gill HS; Kang SM; Quan FS; Compans RW
Expert Opin Drug Deliv; 2014 Apr; 11(4):615-27. PubMed ID: 24521050
[TBL] [Abstract][Full Text] [Related]
31. Microneedle technologies for (trans)dermal drug and vaccine delivery.
van der Maaden K; Jiskoot W; Bouwstra J
J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
[TBL] [Abstract][Full Text] [Related]
32. A grading system for local skin reactions developed for clinical trials of an intradermal and transcutaneous ETEC vaccine.
Gutiérrez RL; Porter CK; Jarell A; Alcala A; Riddle MS; Turiansky GW
Vaccine; 2020 May; 38(21):3773-3779. PubMed ID: 32253098
[TBL] [Abstract][Full Text] [Related]
33. [From basic principles to clinical applications on transcutaneous vaccine].
Okada N
Yakugaku Zasshi; 2013; 133(12):1363-72. PubMed ID: 24292185
[TBL] [Abstract][Full Text] [Related]
34. [New routes of administration: epidermal, transcutaneous mucosal ways of vaccination].
Denis F; Alain S; Ploy MC
Med Sci (Paris); 2007 Apr; 23(4):379-85. PubMed ID: 17433227
[TBL] [Abstract][Full Text] [Related]
35. An update on the application of physical technologies to enhance intradermal and transdermal drug delivery.
Herwadkar A; Banga AK
Ther Deliv; 2012 Mar; 3(3):339-55. PubMed ID: 22833994
[TBL] [Abstract][Full Text] [Related]
36. Mass vaccination: solutions in the skin.
Glenn GM; Kenney RT
Curr Top Microbiol Immunol; 2006; 304():247-68. PubMed ID: 16989274
[TBL] [Abstract][Full Text] [Related]
37. [Development of a transcutaneous vaccination system using a hydrogel patch].
Ishii Y; Okada N; Nakagawa S
Nihon Rinsho; 2008 Oct; 66(10):1848-50. PubMed ID: 18939480
[No Abstract] [Full Text] [Related]
38. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery.
Babiuk S; Baca-Estrada M; Babiuk LA; Ewen C; Foldvari M
J Control Release; 2000 May; 66(2-3):199-214. PubMed ID: 10742580
[TBL] [Abstract][Full Text] [Related]
39. Intradermal naked plasmid DNA immunization: mechanisms of action.
Elnekave M; Furmanov K; Hovav AH
Expert Rev Vaccines; 2011 Aug; 10(8):1169-82. PubMed ID: 21854310
[TBL] [Abstract][Full Text] [Related]
40. Overcoming or circumventing the stratum corneum barrier for efficient transcutaneous immunization.
Chen Z; Lv Y; Qi J; Zhu Q; Lu Y; Wu W
Drug Discov Today; 2018 Jan; 23(1):181-186. PubMed ID: 28988995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
